1
项与 CH505w53(NIAID) 相关的临床试验A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adult Participants
The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs adjuvanted with GLA-SE in healthy, HIV-uninfected adults.
100 项与 CH505w53(NIAID) 相关的临床结果
100 项与 CH505w53(NIAID) 相关的转化医学
100 项与 CH505w53(NIAID) 相关的专利(医药)
100 项与 CH505w53(NIAID) 相关的药物交易